Cargando…

T234. MEASURING PERSONAL RECOVERY IN PEOPLE WITH A PSYCHOTIC DISORDER BASED ON CHIME: A COMPARISON OF RELIABILITY AND VALIDITY PROPERTIES ON THREE VALIDATED MEASURES

BACKGROUND: Living well in spite of residual symptoms of mental illness is measured with the construct of personal recovery. The CHIME framework might be suitable to evaluate personal recovery measures and guide instrument choice. METHODS: Three validated measures were evaluated in Dutch patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sjoerd Vogel, Jelle, Bruins, Jojanneke, Halbersma, Levi, Janine Lieben, Rianne, de Jong, Steven, Van der Gaag, Mark, Castelein, Stynke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session III
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234061/ http://dx.doi.org/10.1093/schbul/sbaa029.794

Ejemplares similares

Measuring personal recovery in people with a psychotic disorder based on CHIME: A comparison of three validated measures
por: Vogel, Jelle Sjoerd, et al.
Publicado: (2020)

S42. QUALITATIVE ANALYSIS OF CLINICIANS’ PERSPECTIVES ON THE USE OF A COMPUTERIZED DECISION AID IN THE TREATMENT OF PSYCHOTIC DISORDERS
por: Roebroek, Lukas, et al.
Publicado: (2020)

Qualitative analysis of clinicians’ perspectives on the use of a computerized decision aid in the treatment of psychotic disorders
por: Roebroek, Lukas O., et al.
Publicado: (2020)

One-Month versus Three-Month Formulation of Paliperidone Palmitate Treatment in Psychotic Disorders: Patients’, Relatives’, and Mental Health Professionals’ Perspectives
por: Spoelstra, S Kor, et al.
Publicado: (2022)

T91. THE POSITIVE AND NEGATIVE SYNDROME SCALE SUPERIOR TO A SELF-REPORT QUESTIONNAIRE IN THE PHARMACOTHERAPY MONITORING AND OUTCOME SURVEY
por: Bartels-Velthuis, Annegien, et al.
Publicado: (2020)

T140. PERSONALITY AND NEUROCOGNITIVE CORRELATES OF PSYCHOTIC-LIKE EXPERIENCES
por: Blain, Scott, et al.
Publicado: (2020)

T43. PREDNISOLONE VERSUS PLACEBO AS AUGMENTATION THERAPY IN PSYCHOTIC DISORDERS
por: Lyliana, Nasib, et al.
Publicado: (2020)

T21. DEVELOPMENT OF PROTEOMIC PREDICTION MODELS FOR OUTCOMES IN THE CLINICAL HIGH RISK STATE AND PSYCHOTIC EXPERIENCES IN ADOLESCENCE: MACHINE LEARNING ANALYSES IN TWO NESTED CASE-CONTROL STUDIES
por: Mongan, David, et al.
Publicado: (2020)

T112. PTSD AS A MEDIATOR OF THE RELATIONSHIP BETWEEN TRAUMA AND PSYCHOTIC EXPERIENCES
por: Strelchuk, Daniela, et al.
Publicado: (2020)

T123. RISK FACTORS FOR PSYCHOTIC DISORDERS WITHIN MIGRANT GROUPS IN CANADA
por: Anderson, Kelly, et al.
Publicado: (2020)

T56. RISKY DECISION-MAKING IMPAIRMENT IN EARLY-STAGE PSYCHOTIC BIPOLAR DISORDER
por: Chung Man Ng, Mary, et al.
Publicado: (2020)

T104. PSYCHOTIC-LIKE EXPERIENCES AND PROBLEMATIC GAMING BEHAVIOR IN ONLINE GAME FORUMS
por: Santesteban-Echarri, Olga, et al.
Publicado: (2020)

T87. CHANGING RATES OF PAST-YEAR CANNABIS USE BY PEOPLE WITH A PSYCHOTIC DISORDER
por: Waterreus, Anna, et al.
Publicado: (2020)

T215. THE ANTIPSYCHOTIC ACTION OF HALOPERIDOL IN PSYCHOTIC-LIKE RATS REQUIRES PRESYNAPTIC VESICULAR ACCUMULATION
por: Müller, Christian, et al.
Publicado: (2020)

T124. ATOPY INCREASES RISK OF PSYCHOTIC EXPERIENCES: A LARGE POPULATION-BASED STUDY
Publicado: (2020)

T82. THE IMPACT OF SMOKING ON LIFE EXPECTANCY IN PSYCHOTIC DISORDERS, AN ELECTRONIC CASE REGISTER COHORT STUDY
por: Chesney, Edward, et al.
Publicado: (2020)

T195. PSYCHOTIC DISORDERS IN PATIENTS WHO USE SYNTHETIC CANNABINOIDS: CLINICAL CHARACTERISTICS AND PATIENT PROFILE
por: Skriabin, Valentin, et al.
Publicado: (2020)

T101. ABERRANT SALIENCE PREDICTS PSYCHOTIC-LIKE AND DISORGANIZED SYMPTOMS IN DAILY LIFE: AN EXPERIENCE SAMPLING STUDY
Publicado: (2020)

T5. STRESS SENSITIZATION AS THE UNDERLYING MECHANISM LINKING CHILDHOOD TRAUMA AND PSYCHOTIC-LIKE SYMPTOMS IN NONCLINICAL YOUNG ADULTS
por: Torrecilla, Pilar, et al.
Publicado: (2020)

T128. ATTACHMENT REPRESENTATIONS IN CHILDREN AT FAMILIAL HIGH RISK OF SEVERE MENTAL DISORDERS. ASSOCIATIONS WITH PSYCHOPATHOLOGY, LEVEL OF FUNCTIONING, AND PSYCHOTIC EXPERIENCES
por: Gregersen, Maja, et al.
Publicado: (2020)

T158. NO ALTERATION OF PITUTARY VOLUME IN PATIENTS WITH FIRST-EPISODE SCHIZPHRENIA BUT A TREND OF ENLARGEMENT IN NON-PSYCHOTIC FIRST-DEGREE RELATIVES
por: Chu, Min-yi, et al.
Publicado: (2020)

T241. INCIDENCE AND SOCIO-DEMOGRAPHIC/CLINICAL CHARACTERISTICS OF PSYCHOTIC DISORDERS IN INDIA, NIGERIA AND TRINIDAD: PRELIMINARY BASELINE FINDINGS FROM INTREPID II
por: Roberts, Tessa, et al.
Publicado: (2020)

T246. RISK FACTORS FOR PSYCHOTIC RELAPSE IN CHRONIC SCHIZOPHRENIA AFTER DOSE-REDUCTION OR DISCONTINUATION OF ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Bogers, Jan, et al.
Publicado: (2020)

T36. NEURAL CHANGES FOLLOWING A BODY-ORIENTED RESILIENCE THERAPY WITH ELEMENTS OF KICKBOXING FOR INDIVIDUALS WITH A PSYCHOTIC DISORDER: A RANDOMIZED CONTROLLED TRIAL
por: van der Stouwe, Elisabeth, et al.
Publicado: (2020)

T29. CHILDHOOD PSYCHOPATHOLOGY ACROSS 12 YEARS PREDICTS ADULT PSYCHOTIC-LIKE EXPERIENCES: A PARALLEL TWO-PART PIECEWISE LATENT GROWTH CURVE MODEL
por: Ka-Yee Wong, Keri, et al.
Publicado: (2020)

T88. VALIDATION OF THE KOREAN VERSION OF THE 15-ITEM COMMUNITY ASSESSMENT OF PSYCHIC EXPERIENCES (CAPE-15) IN A COLLEGE POPULATION
por: Kim, Sung-Wan, et al.
Publicado: (2020)

T103. THE EFFECT OF VIRTUAL REALITY COGNITIVE BEHAVIORAL THERAPY ON PARANOIA AND MOOD STATES
por: Geraets, Chris, et al.
Publicado: (2020)

T38. POSTER PRESENTATION: HAMLETT: HANDLING ANTIPSYCHOTIC MEDICATION, A LONGTERM EVALUATION OF TARGETED TREATMENT A PRAGMATIC SINGLE-BLIND RANDOMISED CONTROLLED TRIAL OF CONTINUATION VERSUS DISCONTINUATION OF PSYCHOTIC MEDICATION
por: van‘t Hag, Erna
Publicado: (2020)

T187. ATHENS MULTIFAMILY THERAPY PROJECT THE ATHENS MULTIFAMILY THERAPY PROJECT (A- MFTP) PROVIDES SYSTEMIC MULTIFAMILY GROUP THERAPY TO YOUTHS WHO EXPERIENCED A FIRST PSYCHOTIC EPISODE (FEP) AND THEIR FAMILIES
por: Selakovic, Mirjana, et al.
Publicado: (2020)

T186. IMPACT OF A STRUCTURED VALIDATED FAMILY PSYCHOEDUCATIONAL PROGRAM (PROFAMILLE) ON MENTAL HEALTH CARE OF PEOPLE WITH SCHIZOPHRENIA SPECTRUM DISORDERS: PRELIMINARY RESULTS
por: Bralet, Marie-Cécile, et al.
Publicado: (2020)

T69. CORRELATION BETWEEN PERFORMANCE-BASED AND INTERVIEW-BASED COGNITIVE MEASUREMENTS IN PATIENTS WITH SCHIZOPHRENIA
por: Jeon, Dong-wook, et al.
Publicado: (2020)

Validation of the Comprehensive Inventory of Mindfulness Experiences (CHIME) in Portuguese Children
por: Magalhães, Sofia, et al.
Publicado: (2022)

T105. VERBAL MEMORY MEASUREMENT TOWARDS DIGITAL PERSPECTIVES IN FIRST-EPISODE PSYCHOSIS: A SYSTEMATIC REVIEW STUDY
por: Kilciksiz, Can, et al.
Publicado: (2020)

T178. MICROPIPETTE-GUIDED DRUG ADMINISTRATION (MDA) METHOD AS A NOVEL PHARMACOLOGICAL TREATMENT METHOD IN MICE: PRECLINICAL VALIDATION USING RISPERIDONE IN THE MATERNAL IMMUNE ACTIVATION MODEL OF NEURODEVELOPMENTAL DISORDERS
por: Scarborough, Joseph, et al.
Publicado: (2020)

T122. A CROSS-NATIONAL INVESTIGATION OF PSYCHOSIS-LIKE EXPERIENCES IN 13 COUNTRIES INCLUDED IN THE E-CLECTIC STUDY: PSYCHOMETRIC CHALLENGES IN STUDYING THEIR MEASUREMENT
Publicado: (2020)

T44. 12-MONTH FOLLOW UP OF METABOLIC MEASURES FOLLOWING A RANDOMISED CONTROLLED TRIAL OF TREATMENT OF CLOZAPINE ASSOCIATED OBESITY AND DIABETES WITH EXENATIDE (CODEX)
por: Siskind, Dan, et al.
Publicado: (2020)

T33. NEUROIMMUNE MECHANISMS OF PSYCHIATRIC DISORDERS: LONGITUDINAL EVALUATION OF DIFFUSION MEASURES OF EXTRACELLULAR FREE WATER IN A NON-HUMAN PRIMATE MODEL OF MATERNAL IMMUNE ACTIVATION
por: Carter, Cameron, et al.
Publicado: (2020)

Validation of the Children's International Mucositis Evaluation Scale (ChIMES) in paediatric cancer and SCT
por: Jacobs, S, et al.
Publicado: (2013)

Measuring recovery in participants with a schizophrenia spectrum disorder: validation of the Individual Recovery Outcomes Counter (I.ROC).
por: Sportel, B. Esther, et al.
Publicado: (2023)

A Human-Centered Design Approach to Develop Oral Health Nursing Interventions in Patients with a Psychotic Disorder
por: Kuipers, Sonja, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_68tp85svn227jhn36r4elq5pu4